(Q24242962)

30 October 2023

2

L Amato

L

Amato

1 reference

30 October 2023

1

S Minozzi

S

Minozzi

1 reference

30 October 2023

6

P P Pani

P P

Pani

1 reference

30 October 2023

Michael F Farrell

4

M

Farrell

1 reference

30 October 2023

author name string

Anelise ARL Lima Reisser

5

A A R L

Lima Reisser

1 reference

30 October 2023

Mauricio Silva de Lima

7

M

Silva de Lima

1 reference

30 October 2023

Bernardo GO Soares

8

B

Soares

1 reference

30 October 2023

M Davoli

M

Davoli

3

1 reference

Cochrane Database of Systematic Reviews

30 October 2023

publication date

23 April 2008

0 references

published in

0 references

cites work

A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

A randomized placebo-controlled trial of gabapentin for cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Carbamazepine treatment for cocaine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Phenytoin in the treatment of cocaine abuse: a double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Tiagabine increases cocaine‐free urines in cocaine‐dependent methadone‐treated patients: results of a randomized pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

A randomized double-blind study of carbamazepine in the treatment of cocaine abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

A pilot trial of topiramate for the treatment of cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Carbamazepine and cocaine-cue reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Carbamazepine treatment of cocaine dependence: a placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Outcome predictors in cocaine dependence treatment trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Carbamazepine for cocaine addiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Cocaine reduction in unmotivated crack users using carbamazepine versus placebo in a short-term, double-blind crossover design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Smoked cocaine discrimination in humans: effects of gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Smoked cocaine self-administration by humans is not reduced by large gabapentin maintenance doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Effects of carbamazepine on acute responses to smoked cocaine-base in human cocaine users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Cocaine Rapid Efficacy Screening Trials (CREST): lessons learned.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Cocaine Rapid Efficacy Screening Trial (CREST): a paradigm for the controlled evaluation of candidate medications for cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Divalproex utility in bipolar disorder with co-occurring cocaine dependence: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Tiagabine affects the subjective responses to cocaine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Pharmacotherapy and other treatments for cocaine abuse and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Effects of lamotrigine on behavioral and cardiovascular responses to cocaine in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

The Cochrane collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Characteristics and pretreatment behaviors of clients entering drug abuse treatment: 1969 to 1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Pharmacotherapeutic interventions for cocaine abuse: present practices and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Mechanisms of action of antiepileptic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Methadone maintenance at different dosages for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Replacement medication for cocaine dependence: methylphenidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

The assessment of anxiety states by rating

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Incentives improve outcome in outpatient behavioral treatment of cocaine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

The neurobiology of drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Antidepressants for cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

The Fifth Edition of the Addiction Severity Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Benzodiazepines for alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Anticonvulsants for alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Dopamine agonists for cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Change in health-related problems of cocaine consumption in Catalonia, Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

The addicted human brain: insights from imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Anticonvulsant drugs in the treatment of substance withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

Effects of phenytoin on cocaine self-administration in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Lamotrigine in patients with bipolar disorder and cocaine dependence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006754.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Recreational drug consumers: who seeks treatment?

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD006754.PUB2

An Inventory for Measuring Depression

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD006754.PUB2

Dreams of depressed patients. Characteristic themes in manifest content

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD006754.PUB2

Impact of desipramine or carbamazepine on patient retention in outpatient cocaine treatment: preliminary findings.

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD006754.PUB2

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD006754.PUB2

Antipsychotic medications for cocaine dependence

9 February 2024

1 reference